A
AKUMS
vs
A
A
Over the past 12 months, AKUMS has outperformed A, delivering a return of -4% compared to the A's 10% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
A
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
|
472.6
INR
|
|||||
|
Agilent Technologies Inc
NYSE:A
|
121.98
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
AKUMS, A
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
A
|
Akums Drugs and Pharmaceuticals Ltd
Revenue
|
|||||||||||
|
Agilent Technologies Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
AKUMS, A
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
A
|
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
|
|||||||||
|
Agilent Technologies Inc
NYSE:A
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd | ||||
|
Agilent Technologies Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd | ||||
|
Agilent Technologies Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd | ||||
|
Agilent Technologies Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd | ||||
|
Agilent Technologies Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd | ||||
|
Agilent Technologies Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd | ||||
|
Agilent Technologies Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd | ||||
|
Agilent Technologies Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
A
|
Akums Drugs and Pharmaceuticals Ltd | ||||
|
Agilent Technologies Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
AKUMS, A
Performance By Year
AKUMS, A
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
|
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|